Clin2
NCT07722962Possibly a fitNot yet recruiting

Medication into spinal fluid for severe spinal cord injury

Acute Spinal Cord Injury (SCI)

Part of Brain & nervous system, Injuries & trauma clinical trials.

This study tests whether a new medication given into the spinal fluid can help people who have a severe spinal cord injury (complete injury) regain more function. It’s for those whose injury is not at the very top of the neck and whose spinal cord is not completely torn.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
10 people
Ages
18 years to 89 years
Study type
Interventional

Who can take part

  • You are between 18 and 89 years old.
  • Your spinal cord injury is 'complete'—meaning no feeling or movement below the injury level—as checked about 3 days after the injury.
  • An MRI shows your spinal cord is not completely torn or cut.
  • Your injury is not at the very top of the neck (the C1-C2 or C2-C3 area).
  • Your spinal cord is not compressed by more than 70% (narrowed by more than 70%).
  • You have not had high-dose steroid treatment for this injury, and you do not have a history of cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06677229Recruiting· Phase 1/Phase 2
Safety and effectiveness of TZ-161 for spinal cord injury

This trial tests a new medicine called TZ-161 in people who have recently had a spinal cord injury in the chest area. The goal is to see if it is safe and can help improve movement.

Córdoba
NCT07090473Recruiting
Electrical stimulation for recent spinal cord injury recovery

This trial tests whether a mild electrical stimulation (called TENS) can help recovery after a recent spinal cord injury. It is for people who are already in the ICU with a drain in their lower back and had a blunt injury within the past 12 hours.

San Francisco, California
NCT07840196Recruiting· Phase 1
Investigational drug NG004 for recent spinal cord injury

This trial tests a new drug called NG004 given by injection around the spinal cord. It aims to help people with recent incomplete spinal cord injuries recover function. The drug is given within the first month after injury and may be an option for those who meet the health criteria.

Bayreuth
NCT05739734Not yet recruiting· Early Phase 1
Safety of a new treatment for spinal cord injury

This study tests whether a new medicine called CRIS100 is safe for people who have just had a spinal cord injury. It's given early after injury (within 72 hours) to see if it can help, and the trial focuses on people with a specific type of injury (complete, mid-back).

NCT07105878Recruiting
Epidural stimulation for spinal cord injury recovery

This trial tests whether an implanted device that sends electrical pulses to the spinal cord can help people with spinal cord injuries regain movement. It is for those who have not seen recent improvement with rehab.

Hangzhou, Zhejiang
NCT06410001Recruiting· Phase 1/Phase 2
Cervical stimulation study for spinal cord injury recovery

This study tests whether a device placed near the spinal cord in your neck (called an epidural stimulator) can help improve arm and hand function after a spinal cord injury. It's designed for people with a long-term, motor-complete injury between the C4 and C7 levels.

Minneapolis, Minnesota

Hear when a new Acute Spinal Cord Injury (SCI) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.